About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:7867699
Allelic
Composition
Adnpem1Goz/Adnp+
Genetic
Background
C57BL/6N-Adnpem1Goz
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adnpem1Goz mutation (0 available); any Adnp mutation (96 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• a lower number of pups survive at postnatal day 1 (43% versus the expected 50%)

behavior/neurological
• adult naive males (not exposed to foster dams/handling) show long-term memory impairment in the novel object recognition test
• adult mice show increased grooming frequency
• males, but not females, show increased grooming duration
• pups gain the reflex for cliff aversion sooner than wild-type pups
• NAP treated pups gain the rooting reflex later than NAP treated wild-type pups
• however, rooting reflex is not different in untreated mice
• pups acquire the ear twitch reflex earlier than wild-type pups
• surviving pups show delayed surface-righting (pup righting on all 4 paws on a flat surface) and air-righting (righting to the correct orientation midair) indicating delayed acquisition of vestibular reflexes
• treatment with NAP corrects the delayed righting response/vestibular reflexes in pups
• pups gain the auditory startle reflex significantly later than wild-type pups
• females show decreased latency to fall in the hanging wire test
• both males and females exhibit a smaller front base of support
• females, but not males, exhibit slower swing speed with increased duration
• NAP treatment partially corrects the smaller front base of support in males but not in females and corrects the slower swing speed and increased duration in females
• males, but not females, exhibit an increase in footprint length and area
• NAP treatment corrects this increase in footprint length and area
• mice show decreased latency to nociception in the hot plate
• adult naive mice show impaired social recognition
• mice show decreased vocalization syntax complexity
• NAP treatment improves the syntax complexity
• mice show decreased total ultrasonic vocalization during pup-dam separation
• however, NAP treatment has no effect on the decreased vocalization

digestive/alimentary system
• males exhibit an increase in total eubacterial load, Bifidobacterium genus, and Lactobacillus group, as well as decreased loads of Enterobacteriaceae
• females exhibit an increase in bacterial load of Bifidobacterium
• treatment with the microtubule/autophagy-protective ADNP fragment NAPVSIPQ (NAP) restores normal levels of total eubacterial load and normalizes the increased bacterial load of Bifidobacterium in females

growth/size/body
• female, but not male, pups are lighter from P10
• NAP treatment restores normal weight, visible from P10 and reaching significance at P20-21
• female, but not male, pups are shorter from P10

hearing/vestibular/ear
• mice show differences in ear twitch, cliff aversion, and auditory startle reflexes, suggesting delayed hearing

nervous system
• 2-month-old males show hyperphosphorylated tau deposits in the hippocampus and visual cortex
• NAP treatment ameliorates the hyperphosphorylated tau deposits in the hippocampus and visual cortex
• males exhibit an approximate 15% reduction in CA1 hippocampal dendritic spine density
• females exhibit an approximate 16% reduction in spine density in the motor cortex L5 layer
• NAP treatment ameliorates this reduction in dendritic spine density
• females exhibit an approximate 25% decrease in PSD95 volume in the hippocampus (representing immature synapses)
• NAP treatment ameliorates this reduction in PSD95 volume

taste/olfaction
• mice exhibit impaired odor discrimination
• NAP treatment reverses the odor discrimination impairment in females but not males

vision/eye
• females, but not males, exhibit delayed eye opening
• NAP treatment reverses the delay in eye opening
• males exhibit abnormal visual evoked potentials
• NAP treatment reverses abnormalities of visual evoke potentials at all stimulation intensities tested except for the 100 mcd of the P3 waveform

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Helsmoortel-Van Der Aa Syndrome DOID:0070058 OMIM:615873
J:361953


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/17/2024
MGI 6.24
The Jackson Laboratory